Danone to sell Horizon Organic and Wallaby to Platinum Equity
The investment firm, Platinum Equity has signed a definitive agreement to acquire Horizon Organic, the world’s largest USDA organic dairy brand, and Wallaby, an Australian-inspired Greek style yogurt brand, from Danone.
Photo © iStockphoto.com/ ValentynVolkov
The investment firm, Platinum Equity (Los Angeles, CA) has announced the signing of a definitive agreement to acquire Horizon Organic, the world’s largest USDA organic dairy brand, and Wallaby, an Australian-inspired Greek style yogurt brand, from Danone. A report from Reuters states that the sale of the two business was part of the company’s portfolio review and asset rotation program which was announced in March of 2022. The financial details of the sale were not disclosed.
"Premium offerings, including organic and value-added products, are driving the growth in the dairy milk category," said Platinum Equity managing director Adam Cooper, in a press release. "Horizon Organic is a pioneer of that segment and is in position to continue capitalizing on and accelerating the trend."
According to the company’s press release, the estimated value of the U.S. dairy category is $68 billion, with milk bringing in $17 billion of that total. The acquisition remains subject to customary closing conditions and regulatory approval.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
